✦ LIBER ✦

Cementoplasty in the management of painful extraspinal bone metastases: our experience

✍ Scribed by A. Basile; G. Giuliano; V. Scuderi; S. Motta; R. Crisafi; F. Coppolino; E. Mundo; G. Banna; F. Di Raimondo; M. T. Patti

Publisher: Springer
Year: 2008
Tongue: Italian
Weight: 971 KB
Volume: 113
Category: Article
ISSN: 0033-8362
DOI: 10.1007/s11547-008-0314-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Extraspinal Painful Bone Me

Treatment of Extraspinal Painful Bone Metastases with Percutaneous Cementoplasty: A Prospective Study of 50 Patients

✍ Giovanni Carlo Anselmetti; Antonio Manca; Cinzia Ortega; Giovanni Grignani; Feli 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 298 KB

Vertebroplasty in the management of pain

Vertebroplasty in the management of painful bony metastases

✍ Michael Gofeld; Anuj Bhatia; Allen W. Burton 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 342 KB

Combination radiofrequency ablation and

Combination radiofrequency ablation and cementoplasty for palliative treatment of painful neoplastic bone metastasis: experience with 53 treated lesions in 36 patients

✍ Michael David Lane; Huy B. Q. Le; Steven Lee; Casey Young; Manraj K. S. Heran; M 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 257 KB

Clinical features and management of pros

Clinical features and management of prostate cancer with bone metastases: the first report of our Institute

✍ Zhijian Shen; Honglin Xie; Chaojun Wang; Songliang Cai; Liping Xie; Suo Wang; Zh 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 90 KB

Conservative management of renal masses

Conservative management of renal masses in the elderly: our experience

✍ Herman S. Fernando; Sudhir Duvuru; Simon J. Hawkyard 📂 Article 📅 2007 🏛 Springer Netherlands 🌐 English ⚖ 122 KB

Bone markers in the management of patien

Bone markers in the management of patients with skeletal metastases

✍ Laurence M. Demers 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

## Background: Biochemical markers of bone remodeling have been used as surrogate markers to manage patients with metastatic bone disease. markers of the bone resorptive process, such as the bone collagen breakdown products n-telopeptide and c-telopeptide, are useful markers for monitoring the resp